BACKGROUND Although convalescent plasma has been widely used to treat severe
coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its …

Background PrEP Brasil was a demonstration study to assess feasibility of daily oral tenofovir
diphosphate disoproxil fumarate plus emtricitabine provided at no cost to men who have …

Background Despite widespread availability of direct-acting antivirals including generic
formulations, limited progress has been made in the global adoption of hepatitis C virus (HCV) …

The worldwide elderly population is expected to grow by an additional 694 million people by
2025. By that time, there will be approximately two billion elderly people in the world, most …

Background By October 30, 2022, 76,871 cases of mpox were reported worldwide, with
20,614 cases in Latin America. This study reports characteristics of a case series of suspected …

Background Tuberculosis is the most frequent opportunistic infection and the leading cause
of death among persons living with HIV in several low and middle-income countries. …

Introduction We aimed to evaluate daily oral pre‐exposure prophylaxis (PrEP) uptake,
retention, and adherence and predictors of study non‐attendance and low PrEP adherence in a …

The introduction of highly active antiretroviral therapy during the 1990s was crucial to the
decline in the rates of morbidity and death related to the acquired immunodeficiency syndrome (…

Background: The 2022 multicountry mpox outbreak positioned the condition as a public
health emergency of international concern. By May 2023, Brazil ranked second globally in the …

Purpose: Worldwide, the burden of adverse health conditions is substantial among travestis
and transgender women (trans women). Transcendendo, the first trans-specific cohort in a …